Source: Kentucky Board of Pharmacy

KENTUCKY BOARD OF PHARMACY
Directives revised July 29, 2020

The directive placing restrictions on prescriptions for chloroquine, hydroxychloroquine, mefloquine, or azithromycin was repealed at the July 29, 2020 Kentucky Board of Pharmacy meeting.

Program is in Inactive Status effective June 30, 2020 – can be reactivated should the need arise. Temporary license/registration for pharmacists and technicians to practice in the Commonwealth of Kentucky should the need arise during the current State of Emergency.
A temporary license/registration may be granted providing the following requirements are met;
a) the pharmacist/technician be in good standing in his or her original state; and
b) temporary license/registration shall be valid for a period of 90 days, though renewable if the emergency continues.

Kentucky law requires that “all pharmacies shall comply with all sanitation laws and administrative regulations” inclusive of, but not limited to provision of “adequate facilities, separate and distinct from toilets and washrooms, shall be provided for maintaining clean and sanitary conditions” in accordance with 201 KAR 2:090 and 201 KAR 2:180.
“Sanitary” conditions include those sufficient to minimize risk of transmission of a communicable disease within a pharmacy, in accordance with nationally published standards such as the CDC and OSHA. Violation of any provision of these administrative regulations constitutes unethical or unprofessional conduct in accordance with KRS 315.121.
The Board strongly supports efforts by pharmacies and pharmacists to adjust work flows and processes within a pharmacy to reduce the risk of person-to-person coronavirus transmission. Such efforts might include, but are not limited to: not physically handling patient identifications at the point of dispensing; not requiring a physical signature for pick-up of a prescription; increasing use of prescription delivery, drive-thru, and curb services; limiting the number of patients physically entering a pharmacy; encouraging patients to wait in their vehicles; encouraging the use of an appointment system for patients to conduct business; placing physical barriers inside the pharmacy and drive thru; encouraging employees to wear PPE and how often to change PPE; adhering to consistent store cleaning regimens.

The Board emphasises that the pharmacist-in-charge is the person authorised by law to ensure compliance with our pharmacy practice standards. Improper interference with a pharmacist-in-charge carrying out these duties and responsibilities subjects a pharmacy permit holder to potential disciplinary action, up to and including revocation. Likewise, a person licensed by, or registered with, the Board who improperly interferes with a pharmacist-in-charge carrying out these duties and responsibilities, is subject to potential disciplinary action, up to and including revocation. Pharmacist professional judgement is encouraged and depended on during these times of crisis to mitigate the possibilities for both employee and customer COVID-19 exposure. Permit holders shall cooperate with their PIC’s and staff to ensure protection for both their staff and customers.



Related: Oregon Pharmacy Board repeals rule that restricted use of HCQ for COVID-19 infection to patients enrolled in a clinical trial.

Efficacy of hydroxychloroquine confirmed in study of University of Minnesota (Boulware) clinical trial data

Hydroxychloroquine could save up to 100,000 lives if used for COVID-19: Yale epidemiology professor

Irrefutable proof that hydroxychloroquine works: FranceSoir

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories